首页|头孢吡肟/阿维巴坦M-H肉汤中浓度测定方法学建立及在体外动态PK/PD模型中的应用

头孢吡肟/阿维巴坦M-H肉汤中浓度测定方法学建立及在体外动态PK/PD模型中的应用

扫码查看
目的:建立头孢吡肟和阿维巴坦在Mueller-Hinton(M-H)肉汤中浓度测定方法,并于头孢吡肟/阿维巴坦体外动态药代动力学/药效学(phar-macokinetic/pharmacodynamic,PK/PD)模型 中进行初步应用。方法:采用高效液相色谱法(HPLC)对M-H肉汤中头孢吡肟进行测定;采用液质联用法(LC-MS/MS)对M-H肉汤中阿维巴坦进行测定。建立头孢吡肟/阿维巴坦2。5gq8h给药方案下体外动态PK/PD感染模型,进行头孢吡肟/阿维巴坦抗碳青霉烯类耐药肺炎克雷伯菌(carbapenem-re-sistant Klebsiella pneumoniae,CRKP)抗菌作用研究。结果:头孢吡肟和阿维巴坦在0。5-120 μg/mL和0。1-25 μg/mL线性关系良好(r=0。999),定量下限浓度为0。5、0。1 μg/mL,肉汤培养基中头孢吡肟和阿维巴坦的的提取回收率分别为88。0%~101。7%和90。9%~95。2%。日内、日间RSD均小于5。2%。在体外PK/PD模型中,头孢吡肟和阿维巴坦具有良好的拟合度,实测浓度在理论浓度的± 20%范围内。对于 MIC=8 μg/mL和 MIC=16 μg/mL的CRKP,头孢吡肟阿维巴坦2。5 gq8 h的给药方案在24 h时菌落分别下降2。783 Log10 CFU/mL、1。325 Log10 CFU/mL。结论:本研究建立的头孢吡肟及阿维巴坦在肉汤中浓度测定方法灵敏度高、稳定性好。体外动态PK/PD模型显示头孢吡肟阿维巴坦常规给药下对MIC≤8 μg/mL的CRKP具有较好的抗菌活性。
Development and validation of a method for quantitation of ce-fepime/avibactam in M-H broth:application to antibacterial activity using in vitro PK/PD Model
AIM:To establish a method for quanti-tation of cefepime and avibactam in M-H broth,and applicated in the in vitro dynamic PK/PD mod-el.METHODS:The cefepime was also determined using the high-performance liquid chromatography method(HPLC),the avibactam was also determined using the liquid chromatography-mass spectrome-try(LC-MS/MS),an in vitro dynamic PK/PD model was established to study the PK/PD relationship of cefepime/avibactam against carbapenem resistant Klebsiella pneumoniae(CRKP).RESULTS:The linear ranges of cefepime and avibactam were good at(0.5-20)and(0.1-25)μg/mL(r=0.999),and the low-er limit concentrations were 0.5 and 0.1 μg/mL.The extraction recoveries of cefepime and avibac-tam in M-H broth were 88.0%-101.7%and 90.9%-95.2%,the relative standard deviation of intra-day precision and inter-day precision were less than 5.2%.The concentration-time curves were well sim-ulated by the PK/PD model.All observed concentra-tions in each experiment were in the range of 20%of the targeted values.For the CRKP of MIC=8 μg/mL and MIC=16 μg/mL,the colony decreased to 2.783Log10 CFU/mL and 1.325Log10 CFU/mLat the cefepime/avibactam 2.5 g q8 h administration after 24 h.CONCLUSION:The determination method of cefepime and avibactam in broth established in this study has high sensitivity and good stability.For the CRKP with MIC≤8 μg/mL,cefepime/avibactam showed that good anti-CRKP activity under routine administration in vitro dynamic PK/PD model.

cefepimeavibactamHPLCLC-MS/MSin vitro dynamic PK/PD model

颜冰倩、郭思维、李尤、田淼梅、徐兵、蒋蓉、李昕

展开 >

湖南中医药大学,长沙 410208,湖南

长沙市第三医院,长沙 410015,湖南

长沙市抗菌药物临床应用研究所,长沙 410015,湖南

头孢吡肟 阿维巴坦 HPLC LC-MS/MS 体外动态PK/PD模型

抗耐药微生物药物湖南省重点实验室项目湖南省临床医疗技术创新引导项目

2023TP10132021SK53002

2024

中国临床药理学与治疗学
中国药理学会

中国临床药理学与治疗学

CSTPCD北大核心
影响因子:0.97
ISSN:1009-2501
年,卷(期):2024.29(1)
  • 12